BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17418516)

  • 1. Early dietary treatments with Lorenzo's oil and docosahexaenoic acid for neurological development in a case with Zellweger syndrome.
    Tanaka K; Shimizu T; Ohtsuka Y; Yamashiro Y; Oshida K
    Brain Dev; 2007 Oct; 29(9):586-9. PubMed ID: 17418516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary Lorenzo's oil and docosahexaenoic acid treatment for Zellweger syndrome.
    Arai Y; Kitamura Y; Hayashi M; Oshida K; Shimizu T; Yamashiro Y
    Congenit Anom (Kyoto); 2008 Dec; 48(4):180-2. PubMed ID: 18983586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
    Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
    Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
    Ferri R; Chance PF
    Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report.
    Terre'Blanche G; van der Walt MM; Bergh JJ; Mienie LJ
    Lipids Health Dis; 2011 Aug; 10():152. PubMed ID: 21871076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorenzo's oil: a reassessment.
    Poulos A; Robertson EF
    Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
    [No Abstract]   [Full Text] [Related]  

  • 10. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 11. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 12. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
    Zinkham WH; Kickler T; Borel J; Moser HW
    N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma and red blood cell fatty acids in peroxisomal disorders.
    Moser AB; Jones DS; Raymond GV; Moser HW
    Neurochem Res; 1999 Feb; 24(2):187-97. PubMed ID: 9972864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil.
    Tanaka M; Koike R; Kuwabara T
    Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil.
    Kaplan PW; Tusa RJ; Shankroff J; Heller J; Moser HW
    Ann Neurol; 1993 Aug; 34(2):169-74. PubMed ID: 8338341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
    Söderfeldt B
    Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
    [No Abstract]   [Full Text] [Related]  

  • 17. Lorenzo's oil and lymphocytopenia.
    Unkrig CJ; Schröder R; Scharf RE
    N Engl J Med; 1994 Feb; 330(8):577. PubMed ID: 8204158
    [No Abstract]   [Full Text] [Related]  

  • 18. Dietary management of X-linked adrenoleukodystrophy.
    Moser HW; Borel J
    Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
    Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
    Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endocrine disease in adrenoleukodystrophy].
    Girard S; Bruckert E; Turpin G
    Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.